The tumor gene survivin is highly expressed in adult renal tubular cells: Implications for a pathophysiological role in the kidney

American Journal of Pathology

Volumn 171, Issue 5, 2007, Pages 1483-1498

  Lechler, Philipp ^a   Wu, Xiaoqing ^a   Bernhardt, Wanja ^a   Campean, Valentina ^a   Gastiger, Susanne ^a   Hackenbeck, Thomas ^a   Klanke, Bernd ^a   Weidemann, Alexander ^a   Warnecke, Christina ^a   Amann, Kerstin ^a   Engehausen, Dirk ^a   Willam, Carsten ^a   Eckardt, Kai Uwe ^a   Rödel, Franz ^b   Wiesener, Michael Sean ^a,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KIDNEY CANCER; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA INTERFERENCE; TUMOR GENE;

EID: 36349015992     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070132     Document Type: Article

References (70)

1. Gill N, Nally JV Jr, Fatica RA: Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest 2005, 128:2847-2863
2. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996, 334:1448-1460
3. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004, 114:5-14
4. Davis MA, Ryan DH: Apoptosis in the kidney. Toxicol Pathol 1998, 26:810-825
5. Ortiz A, Justo P, Sanz A, Lorz C, Egido J: Targeting apoptosis in acute tubular injury. Biochem Pharmacol 2003, 66:1589-1594
6. Wilson PD: Polycystic kidney disease. N Engl J Med 2004, 350:151-164
7. Altieri DC: The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 2006, 18:609-615
8. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997, 3:917-921
9. Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T, Noel JP: Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol 2000, 7:602-608
10. Zangemeister-Wittke U, Simon HU: An IAP in action: the multiple roles of survivin in differentiation, immunity and malignancy. Cell Cycle 2004, 3:1121-1123
11. Reed JC, Bischoff JR: BIRinging chromosomes through cell division - and survivin' the experience. Cell 2000, 102:545-548
12. Wheatley SP, McNeish IA: Survivin: a protein with dual roles in mitosis and apoptosis. Int Rev Cytol 2005, 247:35-88
13. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396:580-584
14. Skoufias DA, Mollinari C, Lacroix FB, Margolis RL: Human survivin is a kinetochore-associated passenger protein. J Cell Biol 2000, 151:1575-1582
15. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokuhisa T: Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 1999, 96:1457-1462
16. Li F, Altieri DC: Transcriptional analysis of human survivin gene expression. Biochem J 1999, 344:305-311
17. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC, Altieri DC: Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1999, 1:461-466
18. Chen J, Wu W, Tahir SK, Kroeger PE, Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M, Welsh K, Reed JC, Ng SC: Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2000, 2:235-241
19. Schimmer AD: Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004, 64:7183-7190
20. Johnson ME, Howerth EW: Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 2004, 41:599-607
21. Okada H, Mak TW: Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004, 4:592-603
22. Colnaghi R, Connell CM, Barrett RM, Wheatley SP: Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 2006, 281:33450-33456
23. Knauer SK, Kramer OH, Knosel T, Engels K, Rodel F, Kovacs AF, Dietmaier W, Klein-Hitpass L, Habtemichael N, Schweitzer A, Brieger J, Rodel C, Mann W, Petersen I, Heinzel T, Stauber RH: Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J 2007, 21:207-216
24. Knauer SK, Bier C, Habtemichael N, Stauber RH: The survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep 2006, 7:1259-1265
25. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC: Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998, 152:43-49
26. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL, Choo KH: Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000, 10:1319-1328
27. Conway EM, Pollefeyt S, Steiner-Mosonyi M, Luo W, Devriese A, Lupu F, Bono F, Leducq N, Dol F, Schaeffer P, Collen D, Herbert JM: Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 2002, 123:619-631
28. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003, 3:46-54
29. Li F, Brattain MG: Role of the survivin gene in pathophysiology. Am J Pathol 2006, 169:1-11
30. Fukuda S, Pelus LM: Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006, 5:1087-1098
31. Bernhardt WM, Schmitt R, Rosenberger C, Munchenhagen PM, Grone HJ, Frei U, Warnecke C, Bachmann S, Wiesener MS, Willam C, Eckardt KU: Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int 2006, 69:114-122
32. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible faotor-1α and -2α in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002, 13:1721-1732
33. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA: Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 1984, 25:383-390
34. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH, Eckardt KU: Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J 2003, 17:271-273
35. Rödel F, Hoffmann J, Grabenbauer GG, Papadopoulos T, Weiss C, Gunther K, Schick C, Sauer R, Rodel C: High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Strahlenther Onkol 2002, 178:426-435
36. Rödel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, Sauer R, Rodel C: Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005, 65:4881-4887
37. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, Wiesener M, Eckardt KU: Differentiating the functional role of hypoxia-inducible factor (HIF)-1α and HIF-2α (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2α target gene in Hep3B and Kelly cells. FASEB J 2004, 18:1462-1464
38. Nadasdy T, Laszik Z, Blick KE, Johnson LD, Silva FG: Proliferative activity of intrinsic cell populations in the normal human kidney. J Am Soc Nephrol 1994, 4:2032-2039
39. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ, Boman BM: Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001, 61:8664-8667
40. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR: Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 2001, 32:119-125
41. Santini D, Abbate A, Scarpa S, Vasaturo F, Biondi-Zoccai GG, Bussani R, De Giorgio F, Bassan F, Camilot D, Di Marino MP, Feroce F, Baldi F, Silvestri F, Crea F, Baldi A: Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction. J Clin Pathol 2004, 57:1321-1324
42. Conway EM, Zwerts F, Van Eygen V, DeVriese A, Nagai N, Luo W, Collen D: Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation. Am J Pathol 2003, 163:935-946
43. Heyman SN, Lieberthal W, Rogiers P, Bonventre JV: Animal models of acute tubular necrosis. Curr Opin Crit Care 2002, 8:526-534
44. Caldas H, Fangusaro JR, Boue DR, Holloway MP, Altura RA: Dissecting the role of endothelial survivin-ΔEx3 in angiogenesis. Blood 2007, 109:1479-1489
45. Mesri M, Wall NR, Li J, Kim RW, Altieri DC: Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 2001, 108:981-990
46. + cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 2001, 98:2091-2100
47. Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD: Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci USA 2005, 102:11480-11485
48. Kobayashi Y, Yukiue H, Sasaki H, Fukai I, Yokoyama T, Kiriyama M, Yamakawa Y, Maeda M, Fujii Y: Developmentally regulated expression of survivin in the human thymus. Hum Immunol 2002, 63:101-107
49. Okada H, Bakal C, Shahinian A, Elia A, Wakeham A, Suh WK, Duncan GS, Ciofani M, Rottapel R, Zuniga-Pflucker JC, Mak TW: Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med 2004, 199:399-410
50. Chiou SK, Moon WS, Jones MK, Tarnawski AS: Survivin expression in the stomach: implications for mucosal integrity and protection. Biochem Biophys Res Commun 2003, 305:374-379
51. Weikert S, Schrader M, Krause H, Schulze W, Muller M, Miller K: The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testes. Cancer Lett 2005, 223:331-337
52. Spaulding B, Pan D, Ghadersohi A, Nielsen G, Jensen S, Gellert F, Ling X, Zhang M, Black A, Li F: Characterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues. Histopathology 2006, 49:622-633
53. Konno R, Yamakawa H, Utsunomiya H, Ito K. Sato S, Yajima A: Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 2000, 6:529-534
54. Ka H, Hunt JS: Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 2003, 163:413-422
55. Botchkareva NV, Kahn M, Ahluwalia G, Shander D: Survivin in the human hair follicle. J Invest Dermatol 2007, 127:479-482
56. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993, 75:229-240
57. Moser M, Pscherer A, Roth C, Becker J, Mucher G, Zerres K, Dixkens C, Weis J, Guay-Woodford L, Buettner R, Fassler R: Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-20. Genes Dev 1997, 11:1938-1948
58. Lorz C, Ortiz A, Justo P, Gonzalez-Cuadrado S, Duque N, Gomez-Guerrero C, Egido J: Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 2000, 11:1266-1277
59. Johnson EA, Svetlov SI, Pike BR, Tolentino PJ, Shaw G, Wang KK, Hayes RL, Pineda JA: Cell-specific upregulation of survivin after experimental traumatic brain injury in rats. J Neurotrauma 2004, 21:1183-1195
60. Deguchi M, Shiraki K, Inoue H, Okano H, Ito T, Yamanaka T, Sugimoto K, Sakai T, Ohmori S, Murata K, Furusaka A, Hisatomi H, Nakano T: Expression of survivin during liver regeneration. Biochem Biophys Res Commun 2002, 297:59-64
61. Chiou SK, Tanigawa T, Akahoshi T, Abdelkarim B, Jones MK, Tarnawski AS: Survivin: a novel target for indomethacin-induced gastric injury. Gastroenterology 2005, 128:63-73
62. Fortugno P, Beltrami E, Plescia J, Fontana J, Pradhan D, Marchisio PC, Sessa WC, Altieri DC: Regulation of survivin function by Hsp90. Proc Natl Acad Sci USA 2003, 100:13791-13796
63. Morita K, Wakui H, Komatsuda A, Ohtani H, Miura AB, Itoh H, Tashima Y: Induction of heat-shock proteins HSP73 and HSP90 in rat kidneys after ischemia, Ren Fail 1995, 17:405-419
64. Bidmon B, Endemann M, Muller T, Arbeiter K, Herkner K, Aufricht C: HSP-25 and HSP-90 stabilize Na,K-ATPase in cytoskeletal fractions of ischemic rat renal cortex. Kidney Int 2002, 62:1620-1627
65. Koch CA, Vortmeyer AO, Diallo R, Poremba C, Giordano TJ, Sanders D, Bornstein SR, Chrousos GP, Pacak K: Survivin: a novel neuroendocrine marker for pheochromocytoma. Eur J Endocrinol 2002, 146:381-388
66. Li F: Role of survivin and its splice variants in tumorigenesis. Br J Cancer 2005, 92:212-216
67. Bander NH, Finstad CL, Cordon-Cardo C, Ramsawak RD, Vaughan ED Jr, Whitmore WF Jr, Oettgen HF, Melamed MR, Old LJ: Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res 1989, 49:6774-6780
68. Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD: Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas. Int J Cancer 2002, 100:30-36
69. Parker AS, Kosari F, Lohse CM, Houston Thompson R, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC: High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 2006, 107:37-45
70. Kindt N, Menzebach A, Van de Wouwer M, Betz I, De Vriesse A, Conway EM: Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced renal failure. FASEB J 2007 [Epub ahead of print]